Opinion and Analysis

Hands off our Grants: the Black Sash’s long battle for justice

A shameful period in South Africa’s recent history

Disciplinary hearings: some schools are flouting the rules

Schools do not have discretion in dealing with learners who contravene the code of conduct

Major shift in housing policy is an opportunity for civil society

We need a comprehensive approach to site and service schemes

South Africa is failing to protect its activists

Killings and victimisation demand urgent measures

Dodgy lotteries: what the SIU can and can’t do

And why it’s important that the NPA joins the fray

Bathabile Dlamini’s conviction sends a message to all public officials

There are consequences for failing in their duties

Lives and eyes lost: excessive use of rubber bullets by police is common

Mthokozisi Ntumba’s death points to bigger SAPS failures

Budget 2022 will reinforce inequality

Less money for public schools and health care, but tax breaks for corporates and individual taxpayers

Long-awaited policy on pregnant learners promises a new dawn

The Department of Education’s Learner Pregnancy Policy is a positive step but has shortcomings

Solitary confinement is illegal. So why is it happening in South African prisons?

Silence on far-reaching changes in housing delivery during SONA

Government is shifting to a site-and-service model rather than building houses

Has the national government abandoned vaccination?

Vaccine uptake has dropped dramatically and there appears to be no push from the President or the national health department to change this

POPI Act: confessions of a convert

This new law will ensure that information about us is kept where it belongs but it is being widely misinterpreted

Health policy has become a confused mess

The health department has withdrawn welcome changes to isolation, quarantine and contact tracing policies

We should not let people suffer and die alone in hospital

Restrictive hospital visitor policies don’t make sense anymore

An optimal vaccine strategy for middle-income countries

A mixture of Chinese-manufactured vaccines and mRNA booster may be the way to go